Article
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Jun 2012
Tsai Tzu-Hsiu, Wu Shang-Gin, Chang Yih-Leong, Wu Chen-Tu, Tsai Meng-Feng, Wei Pin-Fei, Yang Chih-Hsin, Yu Chong-Jen, Yang Pan-Chyr, Shih Jin-Yuan
Abstract excerpt
INTRODUCTION: Tumor tissue is often not obtainable or suitable for molecular-based epidermal growth factor receptor (EGFR) mutational analysis in advanced non-small-cell lung cancer (NSCLC). This retrospective and single-institution study was conducted to evaluate the role of effusion immunocytochemistry using two EGFR mutant-specific antibodies for the detection of relevant EGFR mutations in NSCLC, along with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
